![Sina Bavari](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sina Bavari
Corporate Officer/Principal at TONIX PHARMACEUTICALS HOLDING CORP.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Seth Lederman | M | 66 | 17 years | |
Jessica Morris | F | 46 | 11 years | |
Bruce L. Daugherty | M | 66 | 12 years | |
Bradley Saenger | M | 50 | 10 years | |
David Grange | M | 76 | 6 years | |
Richard Bagger | M | 63 | 4 years | |
Adeoye Olukotun | M | 79 | 6 years | |
R. Stillwell | M | 67 | 1 years | |
Jamie Treco | M | 69 | 5 years | |
Simon Newman | M | - |
Healion Bio, Inc.
![]() Healion Bio, Inc. BiotechnologyHealth Technology Part of Tonix Pharmaceuticals Holding Corp., Healion Bio, Inc. is a biotechnology development company based in Frederick, MD. The company is focused on developing the next generation of antiviral compounds, with two antiviral platforms: the HB-100 series of protease inhibitors and the HB-200/300 series of next-generation antiviral biologics. The HB-100 series is a first-in-class antiviral with an orthogonal mechanism of action to existing drugs. The company was founded by Sina Bavari and Simon Newman, with Simon Newman serving as CEO since incorporation. Healion Bio was acquired by Tonix Pharmaceuticals Holding Corp. on February 01, 2023 for $1.20 million. | - |
Gregory Sullivan | M | 58 | 14 years | |
Margaret Bell | F | 64 | 7 years | |
Carolyn Taylor | F | 64 | 3 years | |
Zeil Rosenberg | M | - | 1 years | |
Anthony Macaluso | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeffrey Rosenfeld | M | - | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 16 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sina Bavari
- Personal Network